Results 131 to 140 of about 4,858 (185)

Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach. [PDF]

PLoS One
Leigh RS, Kaynak BL, Ruskoaho H, Välimäki MJ.   +3 more
europepmc   +1 more source

The BRD4-nucleosome interaction is enhanced modestly and non-selectively by histone acetylation. [PDF]

Nucleic Acids Res
Lambrechts LS, Reid XJ, Kambanis L, Luong C, Kobakhidze E, Daners A, Zhong Y, Patel K, Franck CK, Sani HM, Taylor C, Low JKK, Payne RJ, Mackay JP.   +13 more
europepmc   +1 more source

Therapeutic Targeting of BET Proteins in Sarcoma. [PDF]

Mol Cancer Ther
Riyahi N, Malko R, Shannon HE, Jackson KW, Justice RE, Kreklau K, Saadatzadeh MR, Pollok KE, Pandya PH.   +8 more
europepmc   +1 more source

Sequential epigenetic therapy in AML. [PDF]

Blood
Wang Y, Vakoc CR.
europepmc   +1 more source

Histone acetylation readers Bdf1 and Yaf9 direct SWR1 remodeler to +1 nucleosome. [PDF]

Sci Adv
Ranjan A, Elalaoui E, Tang X, Cha J, Louder RK, Nguyen K, Ye J, Bennani M, Gardner AM, Liu D, Pugh BF, Wu C.   +11 more
europepmc   +1 more source

Bromodomain-Containing Protein 3 [PDF]

, 2020
openaire   +1 more source

Mechanistic insights and in vivo HIV suppression by the BRD4-targeting small molecule ZL0580. [PDF]

PLoS Pathog
Kumar N, Ma Z, Long F, Bonam SR, Lai HT, Wu SY, Chen H, Hazell NC, Bei J, Liu X, Chen Y, Wei Z, Chiang CM, Zhou J, Hu H.   +14 more
europepmc   +1 more source

Bromodomain containing 4 (BRD4) [PDF]

Science-Business eXchange, 2012
openaire   +1 more source

A "Goldilocks Zone" for Recruiting BET Proteins with Bromodomain-1-Selective Ligands. [PDF]

ACS Chem Biol
Mohammed A, Churion K, Danda A, Philips SJ, Ansari AZ.   +4 more
europepmc   +1 more source